The Swiss company Novartis is taking the Indian government to court
over its legislation pertaining to generic drugs. Novartis wants to
make it more difficult for Indian companies to produce generic drugs.
According to a report at nature.com MSF is collecting signature under
a petition calling on Novartis to drop the case. The medical charity
points out that 'India is the pharmacy for the developing world'.
Further information about the background to the MSF campaign can be found here.
The petition is available here
